Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Allscripts exec on ICD-10: 'Appropriate calm'

CHICAGO—Finally. It is finally time for ICD-10. Implementation will happen on Oct. 1 and “for the majority, I think it will go off without a hitch,” said John Beck, Allscripts vice president of revenue cycle solutions, speaking to Clinical Innovation + Technology.

Thumbnail

Uptick expected for healthcare analytics market

The combined annual growth rate in the analytics market during the 10 years from 2010-2020 will be in the 8-11 percent range, according to estimates by IDC Health Insights, making analytics among the top areas of spending growth for hospitals and health systems during this decade.  

Thumbnail

Intermountain CMIO: MU wasn't worth it

CHICAGO—Knowing what we know now, the $29 billion spent on Meaningful Use wasn’t worth it, said Stanley Huff, MD, CMIO of Intermountain Healthcare, delivering the closing keynote at the Physicians IT Symposium during the 2015 HIMSS Annual Conference & Exhibition.

Philips introduces mobile application to keep nurses connected with on-the-go monitoring

Andover, MA – Royal Philips (NYSE: PHG, AEX: PHIA) today announced the latest addition to its portfolio of advanced patient monitoring solutions. The Philips CareEvent mobile application turns a smartphone into a valuable clinical tool to meet the workflow demands for nurses and caregivers who are constantly on the go within the hospital.  

Thumbnail

Industry vet signs on with new company with a fresh view

After 50 years in healthcare, spanning biomedical engineering, health policy, IBM’s Watson supercomputer effort and more, Martin Kohn, MD, has seen a lot. But, he decided to join Sentrian, the first remote patient intelligence company, serving as chief medical scientist.

Liaison Technologies Solves Data Challenges for Healthcare and Life Sciences

ATLANTA, April 9, 2015 – Liaison Technologies, an industry-recognized leader in cloud-based integration and data management offerings, today announced the availability of the Liaison Alloy Health Platform™, a next-generation platform for integrating and managing data across the increasingly interdependent domains of healthcare, health research, and life sciences. 

Thumbnail

Insurance policy premiums to vary based on health data

Life insurance company John Hancock Insurance has launched the John Hancock Vitality program in which policyholders can receive premium discounts in return for sharing their health data and completing certain activities. 

Cerner, Tableau Collaborate to Provide Advanced Data Exploration Capabilities to Health Care Organizations

KANSAS CITY, Mo., April 8, 2015 (GLOBE NEWSWIRE) -- Cerner Corp. has collaborated with Tableau Software to enhance the data discovery experience of health care organizations through interactive data exploration.

Displaying 6521 - 6528 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.